US2010256211A1PendingUtilityA1
Inhibition of Chronic Tissue Transplant Rejection
Est. expiryNov 21, 2022(expired)· nominal 20-yr term from priority
A61K 31/4174A61K 31/417A61K 31/16A61P 37/06A61P 9/00A61P 9/10
52
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Disclosed is a method of inhibiting acute and chronic tissue transplant rejection in a subject with a tissue transplant. The method comprises the step of administering to the subject an effective amount of a compound represented by Formula (I): The values of the variables in Formula (I) are described herein.
Claims
exact text as granted — not AI-modified1 . A method of treating fibrosis in a subject in need thereof, comprising the step of administering an effective amount of a compound represented by the following structural formula:
or a pharmaceutically acceptable salt thereof.
2 . A method of treating chronic vasculopathy in a subject in need thereof, comprising the step of administering an effective amount of a compound represented by the following structural formula:
or a pharmaceutically acceptable salt thereof.
3 . A method of treating atherosclerosis in a subject in need thereof, comprising the step of administering an effective amount of a compound represented by the following structural formula:
or a pharmaceutically acceptable salt thereof.Join the waitlist — get patent alerts
Track US2010256211A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.